Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 101-106 , April 2008

Intrauterine Growth Restriction: Fetal Programming of Hypertension and Kidney Disease

References 

  1. Forsdahl A. Observations throwing light on the high mortality in the county of Finnmark. Is the high mortality today a late effect of very poor living conditions in childhood and adolescence? 1973. Int J Epidemiol. 2002;31:302–308
  2. Barker DJ, Winter PD, Osmond C, et al. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;2:577–580
  3. Barker DJ, Osmond C. Low birth weight and hypertension. BMJ. 1988;297:134–135
  4. Barker DJ. Intrauterine programming of adult disease. Mol Med Today. 1995;1:418–423
  5. Nathanielsz PW. Animal models that elucidate basic principles of the developmental origins of adult diseases. ILAR J. 2006;47:73–82
  6. Fowden AL, Giussani DA, Forhead AJ. Intrauterine programming of physiological systems: Causes and consequences. Physiology (Bethesda). 2006;21:29–37
  7. Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: A systematic review of the literature. J Hypertens. 2000;18:815–831
  8. Langley-Evans SC, Welham SJ, Jackson AA. Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci. 1999;64:965–974
  9. Woods LL, Ingelfinger JR, Nyengaard JR, et al. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res. 2001;49:460–467
  10. Vehaskari VM, Aviles DH, Manning J. Prenatal programming of adult hypertension in the rat. Kidney Int. 2001;59:238–245
  11. Alexander BT. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension. 2003;41:457–462
  12. Gilbert JS, Lang AL, Grant AR, et al. Maternal nutrient restriction in sheep: Hypertension and decreased nephron number in offspring at 9 months of age. J Physiol. 2005;565:137–147
  13. Alexander BT. Fetal programming of hypertension. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1–R10
  14. Langley-Evans SC. Fetal programming of cardiovascular function through exposure to maternal undernutrition. Proc Nutr Soc. 2001;60:505–513
  15. Vehaskari VM, Woods LL. Prenatal programming of hypertension: Lessons from experimental models. J Am Soc Nephrol. 2005;16:2545–2556
  16. Moritz KM, Dodic M, Wintour EM. Kidney development and the fetal programming of adult disease. Bioessays. 2003;25:212–220
  17. Hughson MD, Douglas-Denton R, Bertram JF, et al. Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int. 2006;69:671–678
  18. Goodfellow J, Bellamy MF, Gorman ST, et al. Endothelial function is impaired in fit young adults of low birth weight. Cardiovasc Res. 1998;40:600–606
  19. Brawley L, Itoh S, Torrens C, et al. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res. 2003;54:83–90
  20. Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: Role of nephrogenesis. Kidney Int. 2004;65:1339–1348
  21. Guyton AC, Coleman TG, Cowley AV, et al. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972;52:584–594
  22. Bernstein I, Gabbe SG, Reed KL. Intrauterine growth restriction. In:  Gabbe SG,  Niebyl JR editor. Obstetrics, Normal and Problem Pregnancies. Philadelphia, PA: Churchill Livingstone; 2002;p. 869–891
  23. Pham TD, MacLennan NK, Chiu CT, et al. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol. 2003;285:R962–R970
  24. Murotsuki J, Challis JR, Han VK, et al. Chronic fetal placental embolization and hypoxemia cause hypertension and myocardial hypertrophy in fetal sheep. Am J Physiol. 1997;272:R201–R207
  25. Payne JA, Alexander BT, Khalil RA. Reduced endothelial vascular relaxation in growth-restricted offspring of pregnant rats with reduced uterine perfusion. Hypertension. 2003;42:768–774
  26. Longo LD, Pearce WJ. Fetal cerebrovascular acclimatization responses to high-altitude, long-term hypoxia: A model for prenatal programming of adult disease?. Am J Physiol Regul Integr Comp Physiol. 2005;288:R16–R24
  27. Thornburg KL. Hypoxia and cardiac programming. J Soc Gynecol Investig. 2003;10:251
  28. Tapanainen PJ, Bang P, Wilson K, et al. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res. 1994;36:152–158
  29. Huang ST, Vo KC, Lyell DJ, et al. Developmental response to hypoxia. FASEB J. 2004;18:1348–1365
  30. Shams M, Kilby MD, Somerset DA, et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod. 1998;13:799–804
  31. Lindsay RS, Lindsay RM, Edwards CR, et al. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension. 1996;27:1200–1204
  32. Woods LL, Weeks DA. Prenatal programming of adult blood pressure: Role of maternal corticosteroids. Am J Physiol Regul Integr Comp Physiol. 2005;289:R955–R962
  33. Dickinson H, Walker DW, Wintour EM, et al. Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse. Am J Physiol Regul Integr Comp Physiol. 2006;292:R453–R461
  34. Drake AJ, Walker BR, Seckl JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol. 2005;288:R34–R38
  35. Narkun-Burgess DM, Nolan CR, Norman JE, et al. Forty-five year follow-up after uninephrectomy. Kidney Int. 1993;43:1110–1115
  36. Moritz KM, Wintour EM, Dodic M. Fetal uninephrectomy leads to postnatal hypertension and compromised renal function. Hypertension. 2002;39:1071–1076
  37. Celsi G, Bohman SO, Aperia A. Development of focal glomerulosclerosis after unilateral nephrectomy in infant rats. Pediatr Nephrol. 1987;1:290–296
  38. Woods LL, Weeks DA, Rasch R. Hypertension after neonatal uninephrectomy in rats precedes glomerular damage. Hypertension. 2001;38:337–342
  39. Guron G, Friberg P. An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens. 2000;18:123–137
  40. Guron G. Renal haemodynamics and function in weanling rats treated with enalapril from birth. Clin Exp Pharmacol Physiol. 2005;32:865–870
  41. Woods LL, Rasch R. Perinatal ANG II programs adult blood pressure, glomerular number and renal function in rats. Am J Physiol Regul Integr Comp Physiol. 1998;275:R1593–R1599
  42. Loria A, Reverte V, Salazar F, et al. Changes in renal hemodynamics and excretory function induced by a reduction of ANG II effects during renal development. Am J Physiol Regul Integr Comp Physiol. 2007;293:R695–R700
  43. Crossey PA, Pillai CC, Miell JP. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest. 2002;110:411–418
  44. Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 1994;372:182–186
  45. Longo M, Jain V, Vedernikov YP, et al. Fetal origins of adult vascular dysfunction in mice lacking endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1114–R1121
  46. Huang A, Sun D, Yan C, et al. Contribution of 20-HETE to augmented myogenic constriction in coronary arteries of endothelial NO synthase knockout mice. Hypertension. 2005;46:607–613
  47. Barker DJ, Osmond C, Golding J, et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298:564–567
  48. Leclere N, Andreeva N, Fuchs F, et al. Hypoxia-induced long-term increase of dopamine and tyrosine hydroxylase mRNA levels. Prague Med Rep. 2004;105:291–300
  49. IJzerman RG, Stehouwer CD, de Geus EJ, et al. Low birth weight is associated with increased sympathetic activity: Dependence on genetic factors. Circulation. 2003;108:566–571
  50. Boguszewski MC, Johannsson G, Fortes LC, et al. Low birth size and final height predict high sympathetic nerve activity in adulthood. J Hypertens. 2004;22:1157–1163
  51. Rouwet EV, Tintu AN, Schellings MW, et al. Hypoxia induces aortic hypertrophic growth, left ventricular dysfunction, and sympathetic hyperinnervation of peripheral arteries in the chick embryo. Circulation. 2002;105:2791–2796
  52. Ruijtenbeek K, le Noble FA, Janssen GM, et al. Chronic hypoxia stimulates periarterial sympathetic nerve development in chicken embryo. Circulation. 2000;102:2892–2897
  53. Hiraoka T, Kudo T, Kishimoto Y. Catecholamines in experimentally growth-retarded rat fetus. Asia Oceania J Obstet Gynaecol. 1991;17:341–348
  54. Jones CT, Robinson JS. Studies on experimental growth retardation in sheep. Plasma catecholamines in fetuses with small placenta. J Dev Physiol. 1983;5:77–87
  55. Petry CJ, Dorling MW, Wang CL, et al. Catecholamine levels and receptor expression in low protein rat offspring. Diabet Med. 2000;17:848–853
  56. Alexander BT, Hendon AE, Ferril G, et al. Renal denervation abolishes hypertension in low-birth-weight offspring from pregnant rats with reduced uterine perfusion. Hypertension. 2005;45:754–758
  57. Grigore D, Ojeda NB, Robertson EB, et al. Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring. Am J Physiol Regul Integr Comp Physiol. 2007;293:R804–R811
  58. Riviere G, Michaud A, Breton C, et al. Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. Hypertension. 2005;46:1169–1174
  59. Sahajpal V, Ashton N. Renal function and angiotensin AT1 receptor expression in young rats following intrauterine exposure to a maternal low-protein diet. Clin Sci (Lond). 2003;104:607–614
  60. Vehaskari VM, Stewart T, Lafont D, et al. Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension. Am J Physiol Renal Physiol. 2004;287:F262–F267
  61. Ojeda NB, Grigore D, Yanes LL, et al. Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring. Am J Physiol Regul Integr Comp Physiol. 2007;292:R758–R763
  62. Sherman RC, Langley-Evans SC. Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. Clin Sci (Lond). 2000;98:269–275
  63. Manning J, Vehaskari VM. Low birth weight-associated adult hypertension in the rat. Pediatr Nephrol. 2001;16:417–422
  64. Bauer R, Walter B, Ihring W, et al. Altered renal function in growth-restricted newborn piglets. Pediatr Nephrol. 2000;14:735–739
  65. Mitchell EK, Louey S, Cock ML, et al. Nephron endowment and filtration surface area in the kidney after growth restriction of fetal sheep. Pediatr Res. 2004;55:769–773
  66. Panza JA, Quyyumi AA, Brush JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22–27
  67. Alves GM, Barao MA, Odo LN, et al. L-Arginine effects on blood pressure and renal function of intrauterine restricted rats. Pediatr Nephrol. 2002;17:856–862
  68. Franco Mdo C, Arruda RM, Dantas AP, et al. Intrauterine undernutrition: expression and activity of the endothelial nitric oxide synthase in male and female adult offspring. Cardiovasc Res. 2002;56:145–153
  69. Williams SJ, Hemmings DG, Mitchell JM, et al. Effects of maternal hypoxia or nutrient restriction during pregnancy on endothelial function in adult male rat offspring. J Physiol. 2005;565:125–135
  70. Franco Mdo C, Akamine EH, Aparecida de Oliveira M, et al. Vitamins C and E improve endothelial dysfunction in intrauterine-undernourished rats by decreasing vascular superoxide anion concentration. J Cardiovasc Pharmacol. 2003;42:211–217

 Barbara T. Alexander is supported by NIH grants HL074927 and HL51971.

PII: S1548-5595(08)00002-5

doi: 10.1053/j.ackd.2008.01.001

Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 101-106 , April 2008

Article Tools

* Image Usage & Resolution